JULIAN
CARRETERO ASUNCION
TITULAR DE UNIVERSIDAD
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublications in collaboration with researchers from Institut d'Investigació Biomédica de Bellvitge (4)
2017
-
Genomic profiling of patient-derived xenografts for lung cancer identifies B2M inactivation impairing immunorecognition
Clinical Cancer Research, Vol. 23, Núm. 12, pp. 3203-3213
2015
-
Expression inactivation of SMARCA4 by microRNAs in lung tumors
Human Molecular Genetics, Vol. 24, Núm. 5, pp. 1400-1409
-
PARD3 inactivation in lung squamous cell carcinomas impairs STAT3 and promotes malignant invasion
Cancer Research, Vol. 75, Núm. 7, pp. 1287-1297
2012
-
Novel transcriptional targets of the SRY-HMG box transcription factor SOX4 link its expression to the development of small cell lung cancer
Cancer Research, Vol. 72, Núm. 1, pp. 176-186